Thomas Kassberg

2015

In 2015, Thomas Kassberg earned a total compensation of $2.3M as Chief Business Officers and Executive Vice President at Ultragenyx Pharmaceutical, a 375% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$165,750
Option Awards$1,378,004
Salary$390,000
Stock Awards$373,516
Other$30,996
Total$2,338,266

Kassberg received $1.4M in option awards, accounting for 59% of the total pay in 2015.

Kassberg also received $165.8K in non-equity incentive plan, $390K in salary, $373.5K in stock awards and $31K in other compensation.

Rankings

In 2015, Thomas Kassberg's compensation ranked 4,108th out of 13,638 executives tracked by ExecPay. In other words, Kassberg earned more than 69.9% of executives.

ClassificationRankingPercentile
All
4,108
out of 13,638
70th
Division
Manufacturing
1,501
out of 5,190
71st
Major group
Chemicals And Allied Products
549
out of 1,854
70th
Industry group
Drugs
434
out of 1,528
72nd
Industry
Pharmaceutical Preparations
340
out of 1,182
71st
Source: SEC filing on April 27, 2018.

Kassberg's colleagues

We found five more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2015.

2015

John Pinion

Ultragenyx Pharmaceutical

Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research

2015

Jayson Dallas

Ultragenyx Pharmaceutical

Chief Commercial Officer and Executive Vice President

2015

Emil Kakkis

Ultragenyx Pharmaceutical

Chief Executive Officer

2015

Dennis Huang

Ultragenyx Pharmaceutical

Chief Technical Operations Officer and Senior Vice President

2015

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

News

In-depth

You may also like